These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10587841

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG.
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [Abstract] [Full Text] [Related]

  • 4. Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.
    Thivolet C, Nicolino M, Monbeig S, Estour B, Halimi S, Robert M, Orgiazzi J, Chatelain P, GRADI study.
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):279-85. PubMed ID: 12442065
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM, Lempainen J, Laine AP, Toppari J, Veijola R, Vähäsalo P, Ilonen J, Siljander H, Knip M.
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
    Karjalainen JK.
    Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
    Greenbaum CJ, Sears KL, Kahn SE, Palmer JP.
    Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.